EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bone Turnover Markers: Basic Biology to Clinical Applications

Marian Schini iD, Tatiane Vilaca, Fatma Gossiel iD, Syazrah Salam, Richard Eastell iD

Endocrine Reviews · 08.05.2023 · 44 (3) · 417-473

DOI: 10.1210/endrev/bnac031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Reviews, online erschienen am 13.12.2022. Verfasst von Marian Schini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2HQ, UK. Hauptthemen laut MEDLINE: Collagen Type I, Bone Resorption. Die Arbeit wurde bisher 399-mal zitiert (Crossref) und nennt 548 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone turnover markers (BTMs) are used widely, in both research and clinical practice. In the last 20 years, much experience has been gained in measurement and interpretation of these markers, which include commonly used bone formation markers (bone alkaline phosphatase, osteocalcin, and procollagen I N-propeptide); and commonly used resorption markers (serum C-telopeptides of type I collagen, urinary N-telopeptides of type I collagen, and tartrate-resistant acid phosphatase type 5b). BTMs are usually measured by enzyme-linked immunosorbent assay or automated immunoassay. Sources contributing to BTM variability include uncontrollable factors (eg, age, gender, ethnicity) and controllable factors, particularly relating to collection conditions (eg, fasting/feeding state, and timing relative to circadian rhythms, menstrual cycling, and exercise). Pregnancy, season, drugs, and recent fracture(s) can also affect BTMs. BTMs correlate with other methods of assessing bone turnover, such as bone biopsies and radiotracer kinetics, and can usefully contribute to diagnosis and management of several diseases such as osteoporosis, osteomalacia, Paget’s disease, fibrous dysplasia, hypophosphatasia, primary hyperparathyroidism, and chronic kidney disease–mineral bone disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type IBone ResorptionHumansAcid PhosphataseAlkaline PhosphataseBone RemodelingBiology

Stichwörter der Autor:innen

C-telopeptides of type I collagenbiochemical markers of bone turnoverbone alkaline phosphataseosteocalcintartrate-resistant acid phosphatase 5burinary N-telopeptides of type I collagen

Substanzen

Collagen Type IAcid PhosphataseAlkaline Phosphatase

Autor:innen und Institutionen

  • Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2HQ, UK.
  • Metabolic Bone Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AU, UK.

ORCID-Profile: Marian Schini, Fatma Gossiel, Richard Eastell

Förderung

  • Medical Research Council

Zitieren

APA

Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R. (2023). Bone Turnover Markers: Basic Biology to Clinical Applications. Endocrine Reviews, 44(3), 417-473. https://doi.org/10.1210/endrev/bnac031

Vancouver

Schini M, Vilaca T, Gossiel F, Salam S, Eastell R. Bone Turnover Markers: Basic Biology to Clinical Applications. Endocrine Reviews. 2023;44(3):417-473. doi:10.1210/endrev/bnac031

BibTeX
@article{Schini2023,
  author = {Schini, Marian and Vilaca, Tatiane and Gossiel, Fatma and Salam, Syazrah and Eastell, Richard},
  title = {Bone Turnover Markers: Basic Biology to Clinical Applications},
  journal = {Endocrine Reviews},
  year = {2023},
  volume = {44},
  number = {3},
  pages = {417--473},
  doi = {10.1210/endrev/bnac031}
}
Kostenlos starten →